Identification of mineral deposits in the brain on radiological images: A systematic review

European Radiology

Volumn 22, Issue 11, 2012, Pages 2371-2381

  Hernández, Maria Del C Valdés ^a,b   MacOnick, Lucy C ^c   Tan, Elizabeth M J ^c,d   Wardlaw, Joanna M ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b SINAPSE (Scottish Imaging Network A Platform for Scientific Excellence) Collaboration   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Calcium; Copper; CT; Iron; Manganese; Minerals; MRI

Indexed keywords

CALCIUM; COPPER; FERRITIN; HEMOSIDERIN; IRON; IRON OXIDE; MANGANESE; TRANSFERRIN;

COMPUTER ASSISTED TOMOGRAPHY; DEGRADATION; HISTOLOGY; HUMAN; MAGNETISM; MINERALIZATION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; REVIEW; SYSTEMATIC REVIEW;

BRAIN; CALCIUM; COPPER; DIAGNOSTIC IMAGING; FERRITINS; HEMOSIDERIN; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MANGANESE; MINERALS; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84870326333     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2494-2     Document Type: Review

References (58)

1. Aquino D, Bizzi A, Grisoli M et al (2009) Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 252: 165-172
2. Miyajima H, Takahashi Y, Kono S (2003) Aceruloplasminemia, an inherited disorder of iron metabolism. Biometals 16: 205-213
3. O'Brien C, Sung JH, McGeachie RE, Lee MC (1990) Striatonigral degeneration: clinical, MRI and pathologic correlation. Neurology 40: 710-711
4. Duckett S, Galle P, Escourolle R, Poirier J, Hauw JJ (1977) Presence of zinc, aluminium, magnesium in striopalledodentate (SPD) calcifications (Fahr's disease): electron probe study. Acta Neuropathol 38: 7-10
5. De Reuck J, Auger F, Cordonnier C et al (2011) Comparison of 7.0 T T2*-magnetic resonance imaging of cerebral bleeds in postmortem brain sections of Alzheimer patients with their neuropathological correlates. Cerebrovasc Dis 31: 511-517
6. Schenck JF, Zimmerman EA (2004) High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 17: 433-445
7. Schenck JF, Zimmerman EA, Li Z et al (2006) High-field magnetic resonance imaging of brain iron in Alzheimer disease. Top Magn Reson Imaging 17: 41-50
8. Penke L, Valdés Hernández MC, Maniega SM et al (2012) Brain iron deposits are associated with general cognitive ability and cognitive aging. Neurobiol Aging 33: 510-517
9. Duckett S (1991) Neuroradiology. In: Lea & Febiger (eds) The pathology of the aging human nervous system, 1st edn. Lea & Febiger, Philadelphia, pp 492
10. Casanova MF, Araque JM (2003) Mineralisation of the basal ganglia: implications for neuropsychiatry, pathology and neuroimaging. Psychiatry Res 121: 59-87
11. Crompton DE, Chinnary PF, Fey C et al (2002) Neuroferritinopathy: a window on the role of iron in neurodegeneration. Blood Cells Mol Dis 29: 522-531
12. Haacke EM, Cheng NY, House MJ et al (2005) Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 23: 1-25
13. Ropele S, de Graaf W, Khalil M et al (2011) MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging 34: 13-21
14. Alafuzoff I (2008) Cerebral amyloid angiopathy, hemorrhages and superficial siderosis. Stroke 39: 2699-2700
15. Akutsu H, Tsuboi K, Sakamoto N, Nose T, Honma S, Jikuya T (2004) Cerebral metastasis from angiosarcoma of the aortic wall: case report. Surg Neurol 61: 68-71
16. Allkemper T, Reimer P, Schueirer G, Peters PE (1998) Study of susceptibility-induced artefacts in GRASE with different echo train length. Magn Reson Imaging 8: 834-838
17. Barkhof F, Verrips A, Wesseling P et al (2000) Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 217: 869-876
18. Bizzi A, Brooks RA, Brunetti A et al (1990) Role of iron and ferritin in MR imaging: a study on primates at different field strengths. Radiology 177: 59-65
19. Boddaert N, Le Quan Sang KH, Rötig A et al (2007) Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 110: 401-408
20. Brass SD, Chen N, Mulkern RD, Bakshi R (2006) Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Reson Imaging 17: 31-40
21. Brooks DJ, Luthert P, Gadian D, Marsden CD (1989) Does signalattenuation on high-field MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels. J Neurol Neurosurg Psychiatry 52: 108-111
22. Curtis AR, Fey C, Morris CM et al (2001) Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28: 350-354
23. El Tannir El Tayara N, Wolk A, Dhenain M, Delatour B (2007) Transverse relaxation time reflects brain amyloidosis in young APP/PS1 transgenic mice. Magn Reson Med 58: 179-184
24. El Tannir El Tayara N, Delatour B, Le Cudennec C, Guegan M, Volk A, Dhenain M (2006) Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 22: 199-208
25. Fazekas F, Kleinert R, Roob G et al (1999) Histopathologic analysis of foci of signal loss on gradient-echo T2* weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 20: 637-642
26. Feldman HH, Maia LF, Mackenzie IRA, Forster BB, Martzke J, Woolfenden A (2008) Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease. Stroke 39: 2894-2897
27. Gelman N, Gorell JM, Barker PB et al (1999)MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 210: 759-767
28. Higano S, Takahashi S, Kurihara N et al (1997) Supratentorial primary intra-axial tumors in children. MR and CT evaluation. Acta Radiol 38: 945-952
29. Hocq A, Brouette N, Saussez S, Luhmer M, Gillis P, Goussin Y (2009) Variable-field relaxometry of iron-containing human tissues: a preliminary study. Contrast Media Mol Imaging 4: 157-164
30. Jack CR, Wengenack TM, Reyes DA et al (2005) In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J Neurosci 25: 10041-10048
31. Janss AJ, Galetta SL, Freese A et al (1993) Superficial siderosis of the central nervous system: magnetic resonance imaging and pathological correlation. Case report. J Neurosurg 79: 756-760
32. Kawanami T, Kato T, Tominaga M et al (1996) Hereditary ceruloplasmin deficiency: clinicopathological study of a patient. J Neurol Neurosurg Psychiatry 61: 506-509
33. Ketonen L, Keiburtz K, Kazee AM, Tuite M (1996) Putaminal iron deposition in HIV infection. J NeuroAIDS 1: 33-40
34. Kruer MC, Hiken M, Gregory A et al (2011) Novel histopathological findings in molecularly-confirmed pantothenate kinaseassociated neurodegeneration. Brain 134: 947-958
35. Langkammer C, Krebs N, Goessler W et al (2010) Quantitative MR imaging of brain iron: a post-mortem validation study. Radiology 257: 455-462
36. Maeda H, Sato M, Yoshikawa A et al (1997) Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain. Neuroradiology 39: 546-550
37. Meadowcroft MD, Connor JR, Smith MB, Yang QX (2009) MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J Magn Reson Imaging 29: 997-1007
38. Miyajima H, Kono S, Takahashi Y, Sugimoto M, Sakamoto M, Sakai N (2001) Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology 57: 2205-2210
39. Morita H, Ikeda S, Yamamoto K et al (1995) Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 37: 646-656
40. Ogg RJ, Steen RG (1998) Age related changes in brain T1 are correlated with putative iron concentration. Magn Reson Med 40: 749-753
41. Onyszchuk G, Levine SM, Brooks WM, Berman NE (2009) Postacute pathological changes in the thalamus and internal capsule in aged mice following controlled cortical impact injury: a magnetic resonance imaging, iron histochemical, and glial immunohistochemical study. Neurosci Lett 452: 204-208
42. Reimer P, Allkemper T, Schuierer G, Peters RE (1996) Brain imaging: reduced sensitivity of RARE-derived techniques to susceptibility effects. J Comput Assist Tomogr 20: 201-205
43. Saleh A, Wiedermann D, Schroeter M, Jonkmanns C, Jander S, Hoehn M (2004) Central nervous system inflammatory response after cerebral infarction as detected by magnetic resonance imaging. NMR Biomed 17: 163-169
44. Schrag M, McAuley G, Pomakian J et al (2009) Correlation of hypointensities in susceptibility weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol 119: 291-302
45. Schroeter M, Saleh A, Wiedermann D, Hoehn M, Jander S (2004) Histochemical detection of ultrasmall superparamagnetic iron oxide (USPIO) contrast medium uptake in experimental brain ischemia. Magn Reson Med 52: 403-406
46. Takeuchi Y, Yoshikawa M, Tsujino T et al (2002) A case of aceruloplasminaemia: abnormal serum ceruloplasmin protein without ferroxidase activity. J Neurol Neurosurg Psychiatry 72: 543-545
47. Tuite PJ, Provias JP, Lang AE (1996) Atypical dopa responsive parkinsonism in a patient with megalencephaly, midbrain Lewy body disease and some pathological features of Hallervorden- Spatz disease. J Neurol Neurosurg Psychiatry 61: 523-527
48. Vymazal J, Brooks RA, Baumgarner C et al (1996) The relation between brain iron and NMR relaxation times: an in vitro study. Magn Reson Med 35: 56-61
49. Vymazal J, Righini A, Brooks RA et al (1999) T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 211: 489-495
50. Wu G, Xi G, Hua Y, Sagher O (2010) T2* magnetic resonance imaging sequences reflect brain tissue iron deposition following intracerebral haemorrhage. Transl Stroke Res 1: 31-34
51. Sue CM, Crimmins DS, Soo YS et al (1998) Neuroradiological features of six kindreds with MELAS tRNA (Leu) A2343G point mutation: implications for pathogenesis. J Neurol Neurosurg Psychiatry 65: 233-240
52. Chaki H, Furuta S, Matsuda A et al (2000) Magnetic resonance image and blood manganese concentration as indices for manganese content in the brain of rats. Biol Trace Elem Res 74: 245-257
53. Fitsanakis VA, Zhang N, Anderson JG et al (2008) Measuring brain manganese and iron accumulation in rats following 14 weeks of lowdose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol Sci 103: 116-124
54. Fitsanakis VA, ZhangN, Anderson JG et al (2011) Changes in dietary iron exacerbate regional brain manganese accumulation as determined by magnetic resonance imaging. Toxicol Sci 120: 146-153
55. Finkelstein Y, Zhang N, Fitsanakis VA, Avison MJ, Gore JC, Aschner M (2008) Differential deposition of manganese in the rat brain following subchronic exposure to manganese: a T1- weighted magnetic resonance imaging study. Isr Med Assoc J 10: 793-798
56. Wang X, Qian J, He R et al (2006) Delayed changes in T1- weighted signal intensity in a rat model of 15-minute transient focal ischemia studied by magnetic resonance imaging/spectroscopy and synchrotron radiation X-ray fluorescence. Magn Reson Med 56: 474-480
57. Hallgren B, Sourander P (1958) The effect of age on the nonhaemin iron in the human brain. J Neurochem 3: 41-51
58. Loeffer DA, Connor JR, Juneau PL et al (1995) Transferrin and iron in normal, Alzheimer's disease and Parkinson's disease brain regions. J Neurochem 65: 710-724